Jenny Kobin | Head, Investor Relations |
George Lasezkay | President & Chief Executive Officer |
Thomas Ciulla | Chief Medical Officer & Chief Development Officer |
Charles Deignan | Chief Financial Officer |
Zegbeh Jallah | Roth Capital Partners |
Annabel Samimy | Stifle |
Jonathan Wolleben | JMP Securities |
Ladies and gentlemen thank you standing by and welcome to the Clearside Biomedical Third Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Jenny Kobin, Clearside Investor Relations. Thank you and please go ahead madam.